General
AndroGel Maker Win the Third Bellwether Case
AndroGel maker AbbVie, won the verdict in the third bellwether case as the jury found that the testosterone replacement therapy maker was not…
Nexium: MDL No. 2757
Nexium: MDL No. 2757; in re: Proton-pump inhibitor Products liability litigation, created in August 2017, presided by Judge Claire C. Cecchi, in the U.S. District of New Jersey. Other…
Filing of Hip Replacement Lawsuit on the Rise
A metal-on-metal hip litigation, centralized since May 2017 and involving at least 200 Smith & Nephew Birmingham lawsuits, is witnessing a steady inflow of product liability cases. Recently, a lawsuit was filed by a Minnesota man in the U.S.…
Talcum Powder Lawsuit Filed Over Omitted Safety Information
A group of plaintiffs has filed a class action lawsuit against Johnson & Johnson for not updating the Talcum Powder label to warn the consumers, especially women…
PPI Plaintiffs Request Judge to Club 300 Individuals Cases
Gauging filing Short Form Complaint would not suffice to handle the wave of expected PPI lawsuits, Co-Lead Counsel for the plaintiffs filed a proposed case management order (PDF), requesting temporary clubbing of at least 300 plaintiffs…
Defendants Deny Asbestos Presence in Talcum Powder
During the closing arguments of a Mesothelioma lawsuit, the counsel representing defendants Johnson & Johnson and its talc supplier, Imerys Talc America Inc., and Cyprus Amax Minerals Co., an Imerys predecessor, stated that the…
Ovarian Cancer Urges a Woman to File a Lawsuit against J&J
A lawsuit was filed against Johnson & Johnson, Imerys Talc America, and Personal Care Products Council in the U.S. District Court for the District of Massachusetts by a woman from Massachusetts, who alleges that the long-term use of…
Jury Supports AbbVie Again in The Fifth Bellwether Trial
The fifth bellwether trial in the multidistrict litigation (MDL) over AbbVie Inc.'s testosterone replacement therapy (TRT) drug AndroGel, saw Illinois Federal Jury supporting the defendant. During the trial that began on May 7, 2018, a…
3M To Face 1st Bair Hugger System Bellwether Trial on May 14
The first Bellwether trial in Bair Hugger System multidistrict litigation (MDL) commenced on May 14, 2018, in Minnesota Federal Court. According to the plaintiff…
Antidote AndexXa to have a Restricted Release: Portola CEO
AndexXa, the only antidote for Factor Xa blood thinner, approved by the U.S. Food and Drug Administration(FDA) on May 4 to reverse uncontrollable bleeding problems, will be initially available in only those 40 to 50 hospitals where the…